Beta-adrenergic signaling, a novel target for cancer therapy?
Beta-adrenergic signaling, a novel target for cancer therapy? |
|
https://doi.org/10.18632/oncotarget.182
Hildegard M. Schuller
|
| 466-469 |
A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53 |
|
https://doi.org/10.18632/oncotarget.183
Robert I. Glazer
|
| 470-471 |
Refractory chronic lymphocytic leukemia – new therapeutic strategies
Refractory chronic lymphocytic leukemia – new therapeutic strategies |
|
https://doi.org/10.18632/oncotarget.184
Andrea Schnaiter,
and Stephan Stilgenbauer
|
| 472-482 |
Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS)
Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS) |
|
https://doi.org/10.18632/oncotarget.185
Peter Valent,
Attilio Orazi,
Guntram Büsche,
Annette Schmitt-Gräff,
Tracy I. George,
Karl Sotlar,
Berthold Streubel,
Christine Beham-Schmid,
Sabine Cerny-Reiterer,
Otto Krieger,
Arjan van de Loosdrecht,
Wolfgang Kern,
Kiyoyuki Ogata,
Friedrich Wimazal,
Judit Csomor,
Judit Várkonyi,
Wolfgang R. Sperr,
Martin Werner,
Hans Kreipe,
and Hans-Peter Horny
|
| 483-496 |
EGFR-mutated lung cancer: a paradigm of molecular oncology
EGFR-mutated lung cancer: a paradigm of molecular oncology |
|
https://doi.org/10.18632/oncotarget.186
Zhenfeng Zhang,
Amy L. Stiegler,
Titus J. Boggon,
Susumu Kobayashi,
and Balazs Halmos
|
| 497-514 |
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future |
|
https://doi.org/10.18632/oncotarget.187
Karen Mulder,
Sheryl Koski,
Andrew Scarfe,
Quincy Chu,
Karen King,
and Jennifer Spratlin
|
| 515-529 |
Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs |
|
https://doi.org/10.18632/oncotarget.188
Ben Markman,
Rodrigo Dienstmann,
and Josep Tabernero
|
| 530-543 |
The pursuit of oncotargets through understanding defective cell regulation
The pursuit of oncotargets through understanding defective cell regulation |
|
https://doi.org/10.18632/oncotarget.189
Meng Qiao,
Qian Shi,
and Arthur B. Pardee
|
| 544-551 |
Targeting Metabolic Remodeling in Glioblastoma Multiforme
Targeting Metabolic Remodeling in Glioblastoma Multiforme |
|
https://doi.org/10.18632/oncotarget.190
Amparo Wolf,
Sameer Agnihotri,
and Abhijit Guha
|
| 552-562 |
Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells |
|
https://doi.org/10.18632/oncotarget.191
Joshua C. Curtin,
and Matthew V. Lorenzi
|
| 563-577 |
Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia
Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia |
|
https://doi.org/10.18632/oncotarget.192
Antonio Sacco,
Aldo Roccaro,
and Irene M. Ghobrial
|
| 578-582 |
The requirement of p53 for maintaining chromosomal stability during tetraploidization
The requirement of p53 for maintaining chromosomal stability during tetraploidization |
|
https://doi.org/10.18632/oncotarget.193
Chui Chui Ho,
Pok Man Hau,
Miriam Marxer,
and Randy Y.C. Poon
|
| 583-595 |
The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling
The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling |
|
https://doi.org/10.18632/oncotarget.194
Shaheen Sikandar,
Diana Dizon,
Xiling Shen,
Zuomei Li,
Jeffery Besterman,
and Steven M. Lipkin
|
| 596-605 |
Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks
Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks |
|
https://doi.org/10.18632/oncotarget.195
Rachael Elizabeth Hawtin,
David Elliot Stockett,
Oi Kwan Wong,
Cecilia Lundin,
Thomas Helleday,
and Judith Ann Fox
|
| 606-619 |
Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration
Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration |
|
https://doi.org/10.18632/oncotarget.196
Liming Wang,
Jian Zhang,
Sipra Banerjee,
Laura Barnes,
Venkateswara Sajja,
Yiding Liu,
Baochuan Guo,
Yuping Du,
Mukesh K. Agarwal,
David N. Wald,
Qin Wang,
and Jinbo Yang
|
| 620-627 |
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival |
|
https://doi.org/10.18632/oncotarget.197
Desmond G. Powe,
Melanie J. Voss,
Kurt S. Zänker,
Hany O. Habashy,
Andrew R. Green,
Ian O. Ellis,
and Frank Entschladen
|
| 628-638 |
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy |
|
https://doi.org/10.18632/oncotarget.198
Bhavya Rao,
Ingeborg M.M. van Leeuwen,
Maureen Higgins,
Johanna Campbell,
Alastair M. Thompson,
David P. Lane,
and Sonia Lain
|
| 639-650 |
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget |
|
https://doi.org/10.18632/oncotarget.199
Inti Zlobec,
and Alessandro Lugli
|
| 651-661 |
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors |
|
https://doi.org/10.18632/oncotarget.200
Giulia Taraboletti,
Marco Rusnati,
Laura Ragona,
and Giorgio Colombo
|
| 662-673 |
Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer
Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer |
|
https://doi.org/10.18632/oncotarget.201
Yongyi Wang,
Marten van der Zee,
Riccardo Fodde,
and Leen J. Blok
|
| 674-684 |
Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction
Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction |
|
https://doi.org/10.18632/oncotarget.202
Hiroyuki Inuzuka,
Hidefumi Fukushima,
Shavali Shaik,
and Wenyi Wei
|
| 685-690 |
